Sign in

Alice Natelton

Research Analyst at Bank of America

After thorough research, there is no publicly available evidence of an analyst named Alice Natelton working at Bank of America or active in financial research. No LinkedIn profile, analyst ranking, company coverage details, or verified professional credentials could be identified matching this name in the context of Bank of America or the broader Wall Street community. As a result, a comprehensive professional profile meeting your request cannot be generated at this time.

Alice Natelton's questions to REGENERON PHARMACEUTICALS (REGN) leadership

Alice Natelton's questions to REGENERON PHARMACEUTICALS (REGN) leadership • Q4 2024

Question

Alice Natelton from Bank of America asked about EYLEA pricing, referencing a source who claimed Regeneron had not improved contract terms to compete with biosimilars, and questioned if the strategy is to hold price.

Answer

EVP of Commercial, Marion McCourt, stated that the company does not comment on pricing strategy.

Ask Fintool Equity Research AI